App-Quantinova.ai

Triciribine, a Selective Akt Inhibitor, Inhibits Myofibroblast Differentiation and Ameliorates Pulmonary Vascular Remodeling in Pulmonary Hypertension

Maha Abdalla - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Idiopathic pulmonary fibrosis

Triciribine

Down-regulation of BMPR2 in Pulmonary Hypertension Secondary to Lung Fibrosis

Tingting Weng - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Inverted Lung Transplantation: Interposition of Pericardial Conduit for Pulmonary Venous Anastomosis

H. Yamamoto - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Impact of Lung Allograft Oversizing on Pleural Cavity Expansion in Transplant Recipients with Idiopathic Pulmonary Fibrosis

S.H. Roberts - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Review of Lung Transplantation for Patients 65 Years and Older with Idiopathic Pulmonary Fibrosis in Ireland

I. Byrne - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Lung Transplantation for Familial Pulmonary Fibrosis

S.M. Lari - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Lung Transplant Listing of Idiopathic Pulmonary Fibrosis Patients at Pulmonary Fibrosis Care Centers

J. Mooney - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Idiopathic pulmonary fibrosis

N/A

A Comparison of Normal Lung Anatomy to Minimal to Established Fibrosis in Idiopathic Pulmonary Fibrosis

F. Xu - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

The Impact of Palliative Care on Quality of Life, Depression, and Anxiety in Patients with Idiopathic Pulmonary Fibrosis

K. Janssen - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Idiopathic pulmonary fibrosis

N/A

Repurposing an Opioid Receptor Antagonist as a Treatment for Idiopathic Pulmonary Fibrosis

D. Soundararajan - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Epimorph

Derived Suppressor Cells Orchestrate Immunosuppressive Networks in Idiopathic Pulmonary Fibrosis

I. E. Fernandez - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Idiopathic pulmonary fibrosis

Bleomycin

11 Is a Therapeutic Target in Idiopathic Pulmonary Fibrosis

B. Ng - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Bleomycin

Urine Proteomics Identifies Novel Biomarkers of IPF Disease Progression and Resolution

M. Decaris - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Peptidylarginine Deiminase 4 Contributes to the Profibrotic Phenotype of Fibroblasts from Patients with Idiopathic Pulmonary Fibrosis and Promotes Experimental Pulmonary Fibrosis

A. J. Esposito - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Bleomycin

Normalized Vessel Volume from Quantitative Computed Tomography Predicts Survival in Idiopathic Pulmonary Fibrosis

J. Jacob - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Prediction of Progression Using Quantum Particle Swarm Optimization and Its Metrics at Single Time Point HRCT Scan in Subjects with IPF

G. Kim - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Human Lung Bacterial Communities Associated with Clinical Outcome in Patients with Idiopathic Pulmonary Fibrosis

H. Yoon - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

The Jamming Transition Is Dynamically and Structurally Delayed in Idiopathic Pulmonary Fibrosis Bronchial Epithelial

I. T. Stancil - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Uteroglobin

Characterization of GLPG1205 in Mouse Fibrosis Models: A Potent and Selective Antagonist of GPR84 for Treatment of Idiopathic Pulmonary Fibrosis

L. Saniere - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Superoxide dismutase

Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease

S. Matson - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

N/A

Filters

914 Abstracts